Watanabe K, Shibata A, Wakabayashi H, Shimada K, Tsuchihashi H, Nagatomo T
Division of Cardiovascular Research Lab., Tsubame Rosai Hospital, Niigata, Japan.
Biol Pharm Bull. 1993 May;16(5):480-2. doi: 10.1248/bpb.16.480.
The effects of chronic treatment with bunazosin, atenolol, ketanserin and verapamil on the myocardium of the spontaneously hypertensive rat (SHR) were examined by the radioligand binding assay method using [3H]prazosin, [125I]iodocyanopindolol and [3H]nitrendipine binding to alpha 1- and beta 1-adrenergic receptors and Ca2+ binding sites. The norepinephrine concentration in the rat myocardium was also determined. (1) All of these drugs lowered the elevated blood pressure of the SHR. (2) Only ketanserin administration increased the Kd value of the alpha 1-adrenoceptor in the SHR. (3) Administration of atenolol and ketanserin to the SHR decreased the Bmax value of the beta 1-adrenoceptor. (4) Verapamil, bunazosin and atenolol also lowered the Bmax values of the Ca2+ binding sites of SHRs. (5) All drugs except for atenolol lowered the norepinephrine concentration in the myocardium of the SHR. These findings suggest that the SHR has an abnormality of the alpha 1- and beta 1-adrenoceptors and Ca2+ binding site of the myocardium, that the drugs had a beneficial effect on these receptors, that the drugs could also lower the high norepinephrine content in the myocardium of the SHR and that some of these drugs also affected the binding characteristics of other types of membrane receptors.
采用放射性配体结合分析法,利用[3H]哌唑嗪、[125I]碘氰吲哚洛尔和[3H]尼群地平分别与α1-和β1-肾上腺素能受体及Ca2+结合位点结合,研究了布那唑嗪、阿替洛尔、酮色林和维拉帕米长期治疗对自发性高血压大鼠(SHR)心肌的影响。同时测定了大鼠心肌中的去甲肾上腺素浓度。(1)所有这些药物均降低了SHR升高的血压。(2)仅给予酮色林可增加SHR中α1-肾上腺素能受体的解离常数(Kd)值。(3)给SHR给予阿替洛尔和酮色林可降低β1-肾上腺素能受体的最大结合容量(Bmax)值。(4)维拉帕米、布那唑嗪和阿替洛尔也降低了SHR的Ca2+结合位点的Bmax值。(5)除阿替洛尔外,所有药物均降低了SHR心肌中的去甲肾上腺素浓度。这些发现提示,SHR心肌的α1-和β1-肾上腺素能受体及Ca2+结合位点存在异常,这些药物对这些受体具有有益作用,它们还可降低SHR心肌中高含量的去甲肾上腺素,且其中一些药物还影响其他类型膜受体的结合特性。